/Newborn baby died after receiving vitamin D dose
Newborn Baby Died After Receiving Vitamin D Dose

Newborn baby died after receiving vitamin D dose

“Investigations are underway to determine the exact causes of death and whether it is likely to be attributed to Uvesterol D”, specifies the drug agency in a press release.

Vitamin D in oral solution.  (GARO / PHANIE / AFP)

A ten-day-old infant died on December 21 at his home by “heart failure” after the administration of a dose of uvesterol D against vitamin D deficiency, announces the drug agency (ANSM), Monday, January 2. The link between taking the drug and death is not yet clear. “Investigations are underway to determine the exact causes of death and whether it is likely to be attributed to Uvesterol D”, specifies in fact the ANSM in a press release.

Signs of suffocation after administration

The 10-day-old child showed signs of suffocation and went into cardio-respiratory arrest at home. Le Figaro writes that the ANSM was informed of the death the same day “Informally”. Friday, “Or eight days after the accident”, the ANSM alerted the pharmacovigilance centers (CRPV) responsible for monitoring the side effects of health products.

The agency, for its part, claims to be “In close collaboration with the regional pharmacovigilance centers concerned since December 22”. She adds that “The first conclusions of the investigations will be known in the coming days” and that they will be followed by possible measures. “Since 1990, when uvesterol D was put on the market, no death has been attributed to the administration of this product”, reports the agency again.

Several caveats in the past

Uvesterol D is a very common vitamin D drug, produced by the Crinex laboratory. It has been the subject of several warnings in the past, after babies were unwell during its administration. Precautions are indeed necessary during the administration of this medication, in order to prevent “aspiration” in the newborn.

In 2013, the ANSM had mentioned “Reports of malaise and miscarriage in infants, especially premature newborns and infants less than one month old”. She says she asked the Crinex laboratory to put measures in place to minimize the risks. These measures included the delivery of advice sheets to parents by the doctor or pharmacist on how to administer the drug.